↓ Skip to main content

Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system

Overview of attention for article published in Molecular Cancer, November 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
Published in
Molecular Cancer, November 2012
DOI 10.1186/1476-4598-11-86
Pubmed ID
Authors

Zhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, Ling Gu, Li-Ping Chen, Rui Li, Ye-Qiong Xu, Tian-Yi Gao, Guo-Qi Song, Andrew R Hoffman, Shu-Kui Wang, Ji-Fan Hu

Abstract

Colorectal cancer is one of the most common malignant tumors worldwide. Loss of imprinting (LOI) of the insulin-like growth factor 2 (IGF2) gene is an epigenetic abnormality observed in human colorectal neoplasms. Our aim was to investigate the feasibility of using the IGF2 imprinting system for targeted gene therapy of colorectal cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 30%
Student > Ph. D. Student 7 23%
Student > Bachelor 5 17%
Student > Master 2 7%
Professor 1 3%
Other 1 3%
Unknown 5 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 30%
Medicine and Dentistry 5 17%
Biochemistry, Genetics and Molecular Biology 4 13%
Business, Management and Accounting 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 7%
Unknown 8 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2012.
All research outputs
#20,174,175
of 22,687,320 outputs
Outputs from Molecular Cancer
#1,473
of 1,714 outputs
Outputs of similar age
#244,641
of 275,937 outputs
Outputs of similar age from Molecular Cancer
#35
of 35 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,714 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,937 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.